Armenia’s commercial banks purchase about $91.4 mln at intra-banking forex market last week

YEREVAN, March 3. /ARKA/. Armenian commercial banks purchased about $91.4mln at a weighted average rate of 412.15drams per $1 in intra-banking foreign exchange market on February 24-28, the press service of the Central Bank reported.

In the same period, about 7.5mln euros and over 677.7mln rubles were purchased on the intra-banking forex market at weighted average exchange rates of 564.91 drams per €1 and 11.44drams per ruble respectively.

At the same time, about $111.7mln, over €9.7mln and over 120.6mln rubles were sold on the intra-banking forex market at weighted average exchange rates of 413.29drams, 568.30drams and 11.60drams respectively.

Dram loans extended by Armenian banks during the week before (February 17-23) totalled 37.7bln drams; dollar loans amounted to a total of $37.3mln. ($1=413.15drams). N.V. –0–

spot_img

POPULAR

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img